R79.1
BillableAbnormal coagulation profile
Abnormal coagulation profile
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Abnormal or prolonged bleeding time
- Abnormal or prolonged coagulation time
- Abnormal or prolonged partial thromboplastin time [PTT]
- Abnormal or prolonged prothrombin time [PT]
- Low von Willebrand factor
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
- •asymptomatic hyperuricemiaE79.0
- •hyperglycemia NOSR73.9
- •hypoglycemia NOSE16.2
- •neonatal hypoglycemiaP70.3-P70.4
- •specific findings indicating disorder of amino-acid metabolismE70-E72
- •specific findings indicating disorder of carbohydrate metabolismE73-E74
- •specific findings indicating disorder of lipid metabolismE75
- •coagulation defectsD68
Excludes 2
Conditions not included here, but the patient may have both
- •abnormal findings on antenatal screening of motherO28
- •certain conditions originating in the perinatal periodP04-P96
- signs and symptoms classified in the body system chapters
- •signs and symptoms of breast,N63, N64.5
- •abnormalities of lipidsE78
- •abnormalities of platelets and thrombocytesD69
- •abnormalities of white blood cells classified elsewhereD70-D72
- •coagulation hemorrhagic disordersD65-D68
- diagnostic abnormal findings classified elsewhere - see Alphabetical Index
- •hemorrhagic and hematological disorders of newbornP50-P61
- •abnormality of fluid, electrolyte or acid-base balanceE86-E87
Use Additional Code
Additional codes that should follow this code
Related Codes(3)
Also Known As / Clinical Terms(166)
SNOMED CT
- Elevated fibrinogen level123791008
- Fibrinogen in blood above reference range123791008
- Decreased fibrinogen131177005
- Fibrinogen below reference range131177005
- Coag./bleeding tests abnormal165563002
- Coagulation/bleeding tests abnormal165563002
- Prothrombin time abnormal165568006
- Prothrombin time low165569003
- Thrombin time abnormal165575007
- Thrombin time outside reference range165575007
- INR (international normalised ratio) abnormal165583001
- INR (international normalised ratio) outside reference range165583001
- INR (international normalized ratio) abnormal165583001
- INR (international normalized ratio) outside reference range165583001
- International normalised ratio abnormal165583001
- International normalised ratio outside reference range165583001
- International normalized ratio abnormal165583001
- International normalized ratio outside reference range165583001
- Menopause monitoring status243875009
- Intrinsic coagulation pathway finding250328005
- Intrinsic coagulation pathway observation250328005
- Intrinsic coagulation system observation250328005
- Extrinsic coagulation pathway finding250338000
- Extrinsic coagulation pathway observation250338000
- Extrinsic coagulation system observation250338000
- Fibrinogen screening finding250345000
- Fibrinogen screening observation250345000
- INR (international normalised ratio) above reference range313341008
- INR (international normalised ratio) raised313341008
- INR (international normalized ratio) above reference range313341008
- INR (international normalized ratio) raised313341008
- International normalised ratio above reference range313341008
- International normalized ratio above reference range313341008
- Hormone replacement therapy bleed pattern - abnormal390989002
- Prothrombin time increased409674002
- Partial thromboplastin time increased409675001
- Deviation of international normalised ratio from target range413086003
- Deviation of international normalized ratio from target range413086003
- INR - international normalised ratio deviation from target413086003
- INR - international normalized ratio deviation from target413086003
- INR deviation from target413086003
- International normalised ratio deviation from target413086003
- International normalized ratio deviation from target413086003
- Activated partial thromboplastin time finding413432001
- Partial thromboplastin time finding413432001
- Prothrombin time finding415184000
- Clotting time above reference range445164007
- D-dimer above reference range449830004
- Elevated D-dimer449830004
- Thrombin time above reference range1155724002
- Thrombin time below reference range1155725001
- Partial thromboplastin time below reference range1155726000
- INR (international normalised ratio) below reference range1285280000
- INR (international normalised ratio) decreased1285280000
- INR (international normalized ratio) below reference range1285280000
- INR (international normalized ratio) decreased1285280000
- International normalised ratio below reference range1285280000
- International normalized ratio below reference range1285280000
- Hypocoagulability state1290465008
- Hypocoagulable state1290465008
- Coagulation factor inhibitor detected in blood after transfusion of coagulation factors1306792008
- Coagulation factor inhibitor present after transfusion of coagulation factors1306792008
UMLS
- Abnormal coagulation profileC0375576
- Abnormal or prolonged bleeding timeC0151529
- Bleeding time increasedC0151529
- Bleeding time prolongedC0151529
- Increased bleeding timeC0151529
- Prolonged bleeding timeC0151529
- bleeding increased timeC0151529
- bleeding time prolongedC0151529
- increased bleeding timeC0151529
- prolonged bleeding timeC0151529
- Abnormal or prolonged coagulation timeC0151563
- Clotting time increasedC0151563
- Clotting time lengthenedC0151563
- Clotting time prolongedC0151563
- Coagulation time NOS prolongedC0151563
- Coagulation time increasedC0151563
- Coagulation time prolongedC0151563
- Prolonged clotting timeC0151563
- Prolonged whole-blood clotting timeC0151563
- Time coagulation prolongedC0151563
- Abnormal or prolonged partial thromboplastin time [PTT]C2830487
- Abnormal or prolonged prothrombin time [PT]C2830488
- Low von Willebrand factorC5575560
Clinical Terms
- INR (international normalized ratio) decreased
- Decreased fibrinogen
- Clotting time prolonged
- Prolonged bleeding time
- INR (international normalised ratio) raised
- Increased bleeding time
- Partial thromboplastin time below reference range
- Elevated fibrinogen level
- INR (international normalised ratio) below reference range
- International normalized ratio deviation from target
- INR (international normalised ratio) above reference range
- Activated partial thromboplastin time finding
- Deviation of international normalised ratio from target range
- Hormone replacement therapy bleed pattern - abnormal
- Intrinsic coagulation system observation
- Coagulation factor inhibitor detected in blood after transfusion of coagulation factors
- Intrinsic coagulation pathway observation
- Time coagulation prolonged
- Hypocoagulable state
- Coag./bleeding tests abnormal
- INR - international normalized ratio deviation from target
- Bleeding time increased
- Clotting time above reference range
- Prolonged whole-blood clotting time
- Extrinsic coagulation pathway finding
- Coagulation factor inhibitor present after transfusion of coagulation factors
- Coagulation time prolonged
- International normalized ratio abnormal
- Coagulation time increased
- Partial thromboplastin time finding
- INR (international normalized ratio) abnormal
- Bleeding time prolonged
- Fibrinogen screening finding
- Extrinsic coagulation pathway observation
- Fibrinogen screening observation
- International normalised ratio above reference range
- bleeding increased time
- INR - international normalised ratio deviation from target
- Prothrombin time abnormal
- Menopause monitoring status
- INR (international normalised ratio) decreased
- Abnormal or prolonged coagulation time
- Clotting time increased
- Prolonged clotting time
- International normalised ratio below reference range
- Clotting time lengthened
- Prothrombin time finding
- Abnormal or prolonged partial thromboplastin time [PTT]
- International normalized ratio outside reference range
- Thrombin time below reference range
- Elevated D-dimer
- INR (international normalized ratio) raised
- Abnormal or prolonged bleeding time
- INR (international normalized ratio) below reference range
- International normalised ratio outside reference range
- International normalised ratio deviation from target
- Coagulation/bleeding tests abnormal
- International normalized ratio below reference range
- International normalised ratio abnormal
- Extrinsic coagulation system observation
- D-dimer above reference range
- Intrinsic coagulation pathway finding
- INR (international normalised ratio) abnormal
- International normalized ratio above reference range
- Hypocoagulability state
- Partial thromboplastin time increased
- INR (international normalized ratio) above reference range
- INR deviation from target
- Thrombin time abnormal
- INR (international normalized ratio) outside reference range
- Thrombin time outside reference range
- Low von Willebrand factor
- Thrombin time above reference range
- Prothrombin time low
- Abnormal or prolonged prothrombin time [PT]
- Fibrinogen in blood above reference range
- INR (international normalised ratio) outside reference range
- Deviation of international normalized ratio from target range
- Fibrinogen below reference range
- Prothrombin time increased
- Coagulation time NOS prolonged
Frequently Asked Questions
What is the ICD-10 code for abnormal coagulation profile?
The ICD-10-CM code for abnormal coagulation profile is R79.1. The full clinical description is "Abnormal coagulation profile". R79.1 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code R79.1 mean?
ICD-10-CM code R79.1 represents “Abnormal coagulation profile”. It is classified under Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings and is a billable/specific code that can be used on a claim.
Is R79.1 a billable code?
Yes, R79.1 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is R79.1 in?
R79.1 is in Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (codes R00-R99).
What codes cannot be used with R79.1?
R79.1 has Excludes1 notes indicating codes that cannot be used together with it, including: asymptomatic hyperuricemia (E79.0); hyperglycemia NOS (R73.9); hypoglycemia NOS (E16.2); and 5 more.
Are additional codes required with R79.1?
Yes, when using R79.1, also report: any retained foreign body, if applicable (Z18.-).
What SNOMED CT codes does R79.1 map to?
R79.1 maps to 26 SNOMED CT concepts: 413432001, 445164007, 165563002, 1306792008, 449830004, and 21 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for R79.1?
R79.1 is linked to 6 UMLS Concept Unique Identifiers: C0375576, C0151529, C0151563, C2830487, C2830488, and 1 more. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does R79.1 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like abnormal coagulation profile affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of R79.1?
There is no direct ICD-11 mapping available for R79.1 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.